243 related articles for article (PubMed ID: 21228113)
1. Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.
Williams JM; Zhang J; North P; Lacy S; Yakes M; Dahly-Vernon A; Roman RJ
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F983-98. PubMed ID: 21228113
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.
Williams JM; Murphy SR; Wu W; Border JJ; Fan F; Roman RJ
Geroscience; 2022 Dec; 44(6):2845-2861. PubMed ID: 35767209
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats.
Kojima N; Williams JM; Takahashi T; Miyata N; Roman RJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):464-72. PubMed ID: 23492941
[TBL] [Abstract][Full Text] [Related]
4. Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-induced Nephropathy.
Hirata T; Fan F; Fan L; Amin G; White T; Geurts AM; Kojima N; Takahashi T; Miyata N; Williams J; Roman RJ
J Cardiovasc Pharmacol; 2023 Dec; 82(6):445-457. PubMed ID: 37643020
[TBL] [Abstract][Full Text] [Related]
5. Prevention of the progression of renal injury in diabetic rodent models with preexisting renal disease with chronic endothelin A receptor blockade.
Spires D; Poudel B; Shields CA; Pennington A; Fizer B; Taylor L; McPherson KC; Cornelius DC; Williams JM
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F977-F985. PubMed ID: 29846112
[TBL] [Abstract][Full Text] [Related]
6. DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats.
Kato S; Takahashi T; Miyata N; Roman RJ
J Pharmacol Exp Ther; 2020 Feb; 372(2):166-174. PubMed ID: 31801803
[TBL] [Abstract][Full Text] [Related]
7. Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl rats.
Manger WM; Simchon S; Stokes MB; Reidy JJ; Kumar AR; Baer L; Gallo G; Haddy FJ
J Hypertens; 2009 Mar; 27(3):587-98. PubMed ID: 19330919
[TBL] [Abstract][Full Text] [Related]
8. High-Salt Diet Aggravates Endothelial-to-Mesenchymal Transition in Glomerular Fibrosis in Dahl Salt-Sensitive Rats.
Chen HL; Peng K; Zeng DM; Yan J; Huang YQ; Jiang PY; Du YF; Ling X; Wu J
Am J Hypertens; 2023 Nov; 36(12):660-666. PubMed ID: 37179466
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
Yu M; Moreno C; Hoagland KM; Dahly A; Ditter K; Mistry M; Roman RJ
J Hypertens; 2003 Jun; 21(6):1125-35. PubMed ID: 12777949
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective effects of anti-TGF-β antibody and antihypertensive therapies in Dahl S rats.
Murphy SR; Dahly-Vernon AJ; Dunn KM; Chen CC; Ledbetter SR; Williams JM; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R57-69. PubMed ID: 22538513
[TBL] [Abstract][Full Text] [Related]
11. Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats.
Kojima N; Williams JM; Slaughter TN; Kato S; Takahashi T; Miyata N; Roman RJ
Physiol Rep; 2015 Jul; 3(7):. PubMed ID: 26169541
[TBL] [Abstract][Full Text] [Related]
12. Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats.
Chen X; Mori T; Guo Q; Hu C; Ohsaki Y; Yoneki Y; Zhu W; Jiang Y; Endo S; Nakayama K; Ogawa S; Nakayama M; Miyata T; Ito S
Hypertens Res; 2013 Apr; 36(4):361-7. PubMed ID: 23364337
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats.
Nomura M; Nomura S; Mitsui T; Suzuki M; Kobayashi H; Ito T; Itakura A; Kikkawa F; Mizutani S
Am J Hypertens; 2005 Apr; 18(4 Pt 1):538-43. PubMed ID: 15831365
[TBL] [Abstract][Full Text] [Related]
15. Effects of lipid-lowering agents in the Dahl salt-sensitive rat.
Wilson TW; Alonso-Galicia M; Roman RJ
Hypertension; 1998 Jan; 31(1 Pt 2):225-31. PubMed ID: 9453307
[TBL] [Abstract][Full Text] [Related]
16. Restoration of endothelial cell function by chronic cicletanine treatment in Dahl salt-sensitive rats with salt-induced hypertension.
Hirawa N; Uehara Y; Kawabata Y; Akie Y; Ichikawa A; Funahashi N; Goto A; Omata M
Hypertens Res; 1996 Dec; 19(4):263-70. PubMed ID: 8986457
[TBL] [Abstract][Full Text] [Related]
17. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
[TBL] [Abstract][Full Text] [Related]
18. Impaired response of regulator of Gαq signaling-2 mRNA to angiotensin II and hypertensive renal injury in Dahl salt-sensitive rats.
Wu Y; Takahashi H; Suzuki E; Kruzliak P; Soucek M; Uehara Y
Hypertens Res; 2016 Apr; 39(4):210-6. PubMed ID: 26606876
[TBL] [Abstract][Full Text] [Related]
19. Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.
Hirata T; Smith SV; Takahashi T; Miyata N; Roman RJ
J Pharmacol Exp Ther; 2021 Feb; 376(2):240-249. PubMed ID: 33277348
[TBL] [Abstract][Full Text] [Related]
20. Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats.
Hirawa N; Uehara Y; Kawabata Y; Numabe A; Ohshima N; Ono H; Gomi T; Ikeda T; Yagi S; Toyo-oka T
J Hypertens; 1995 Jan; 13(1):81-90. PubMed ID: 7759856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
